Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0699790 (
colon cancer
)
28,837
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Colorectal cancers show significant tumor cell heterogeneity within the same core genetic background. Epithelial-mesenchymal transition (EMT) is an important functional aspect of this heterogeneity and hallmark of colorectal cancer progression. Here, we identify
CYB5R1
, an enzyme involved in oxidative stress protection and drug metabolism, as an indicator of EMT in
colon cancer
. We demonstrate high
CYB5R1
expression in colorectal cancer cells undergoing EMT at the infiltrative tumor edge and reveal an extraordinarily strong association of
CYB5R1
expression with two core EMT gene expression signatures in a large independent
colon cancer
data set from The Cancer Genome Atlas (TCGA). Furthermore, we demonstrate that
CYB5R1
is required for an infiltrative tumor cell phenotype, and robustly linked with poor prognosis in colorectal cancer. Our findings have important implications for
colon cancer
cells undergoing EMT and may be exploited for diagnostic and therapeutic purposes.
...
PMID:CYB5R1 links epithelial-mesenchymal transition and poor prognosis in colorectal cancer. 2712 Jul 83